NCM
RDY icon

Newgate Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Newgate Capital Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-69,755
Closed -$704K – 116
2014
Q4 		$704K Buy
+69,755
New +$734K 0.46% 60

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Newgate Capital Management's RDY Position: Q1 2015 in Review

Newgate Capital Management sold out of Dr. Reddy's Laboratories (RDY) in Q1 2015, closing a stake of 69,755 shares — an estimated $704K sold.

Newgate Capital Management first reported a position in RDY in Q4 2014 and held it in 1 quarter. The position peaked at $704K in Q4 2014. 174 funds tracked by Wall St. Rank hold RDY as of Q1 2015.

  • Newgate Capital Management reported no remaining Dr. Reddy's Laboratories position as of Q1 2015 after selling out during the quarter.
  • Newgate Capital Management sold 69,755 Dr. Reddy's Laboratories shares in Q1 2015, an estimated $704K.
  • Newgate Capital Management first reported a position in Dr. Reddy's Laboratories in Q4 2014 and held it in 1 quarter.
  • Newgate Capital Management's Dr. Reddy's Laboratories position peaked at $704K in Q4 2014.
  • 174 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2015.

Based on Newgate Capital Management's 13F filing for Q1 2015, filed 14 May 2015.